A dynamic prognostic model to predict survival in post–polycythemia vera myelofibrosis

Overview of attention for article published in Blood, January 2008

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

patent: 5 patents

Citations

dimensions_citation: 103 Dimensions

Readers on

mendeley: 81 Mendeley
citeulike: 1 CiteULike

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms

Grant US-11203788-B2

United States of America

TET2 as a diagnostic and prognostic marker in hematopoietic neoplasms

Grant US-10662482-B2

United States of America

Genetic assay to determine prognosis in Polycythemia Vera patients

Grant US-10106855-B2

United States of America

TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms

Application US-9389233-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.